N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors

MLA

Jeff A. Sloan, et al. “N-Terminal Pro Brain Natriuretic Peptide, SST2, and Galectin-3 Levels in Breast Cancer Survivors.” Journal of Clinical Medicine; Volume 10; Issue 15; Pages: 3313, July 2021. EBSCOhost, https://doi.org/10.3390/jcm10153313.

APA

Jeff A. Sloan, Charles L. Loprinzi, Janet E. Olson, Robert A. Vierkant, Antonious Z. Hazim, Fergus J. Couch, Kathryn J. Ruddy, Shruti R. Patel, & Joerg Herrmann. (2021). N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors. Journal of Clinical Medicine; Volume 10; Issue 15; Pages: 3313. https://doi.org/10.3390/jcm10153313

Chicago

Jeff A. Sloan, Charles L. Loprinzi, Janet E. Olson, Robert A. Vierkant, Antonious Z. Hazim, Fergus J. Couch, Kathryn J. Ruddy, Shruti R. Patel, and Joerg Herrmann. 2021. “N-Terminal Pro Brain Natriuretic Peptide, SST2, and Galectin-3 Levels in Breast Cancer Survivors.” Journal of Clinical Medicine; Volume 10; Issue 15; Pages: 3313, July. doi:10.3390/jcm10153313.